Goldman Sachs
PCYC

Goldman Sachs’s PHARMACYCLICS INC PCYC Stock Holding History

Goldman Sachs’s Portfolio PCYC Stock Details PCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-362,834
Closed -$92.9M – 7659
2015
Q1 		$92.9M Buy
362,834
+125,735
+53% +$24.3M 0.03% 688
2014
Q4 		$29M Sell
237,099
-247,532
-51% -$31.6M 0.01% 1549
2014
Q3 		$56.9M Sell
484,631
-226,924
-32% -$25.9M 0.02% 977
2014
Q2 		$63.8M Sell
711,555
-596,383
-46% -$56M 0.02% 936
2014
Q1 		$131M Buy
1,307,938
+340,676
+35% +$44.3M 0.04% 489
2013
Q4 		$102M Buy
967,262
+393,423
+69% +$47.7M 0.03% 629
2013
Q3 		$79.3M Sell
573,839
-80,932
-12% -$8.98M 0.03% 693
2013
Q2 		$52M Buy
+654,771
New +$53.5M 0.02% 881

Other funds holding PCYC

Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Goldman Sachs's PCYC Position: Q2 2015 in Review

Goldman Sachs sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 362,834 shares — an estimated $92.9M sold.

Goldman Sachs first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $131M in Q1 2014. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

  • Goldman Sachs reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
  • Goldman Sachs sold 362,834 PHARMACYCLICS INC shares in Q2 2015, an estimated $92.9M.
  • Goldman Sachs first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
  • Goldman Sachs's PHARMACYCLICS INC position peaked at $131M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.